Back
ESC Premium Access

Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.

Session: Insights from acute coronary syndrome registries
Topic: Epidemiology, Prognosis, Outcome
Speaker: Associate Professor F. Marin (Murcia, ES)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Associate Professor Francisco Marin

Virgen of the Arrixaca University Hospital, Murcia (Spain)
3 presentations
0 follower

5 more presentations in this session

Real world outcomes for clopidogrel versus ticagrelor treated patients with acute coronary syndrome: a systematic literature review and meta-analysis

Speaker: Professor D. Sibbing (Munich, DE)

Access
Abstract
Slides
Thumbnail

One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Access
Abstract
Thumbnail

Ischemic-bleeding balance according to history of prior bleeding in patients with acute coronary syndrome during treatment with dual antiplatelet therapy

Speaker: Ms B. Caneiro-Queija (Vigo, ES)

Access
Abstract
Slides
Thumbnail

Percutaneous coronary intervention in the age of frailty

Speaker: Doctor M. Bergami (Bologna, IT)

Access
Abstract
Slides
Thumbnail

Thrombus aspiration in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden

Speaker: Mr K. Kintis (Athens, GR)

Access
Slides
Thumbnail

Access the full session

Insights from acute coronary syndrome registries

Speakers: Associate Professor F. Marin, Professor D. Sibbing, Doctor M. Esteve Pastor, Ms B. Caneiro-Queija, Doctor M. Bergami...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb